Your browser doesn't support javascript.
loading
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Wechsler, Michael E; Scelo, Ghislaine; Larenas-Linnemann, Désirée E S; Torres-Duque, Carlos A; Maspero, Jorge; Tran, Trung N; Murray, Ruth B; Martin, Neil; Menzies-Gow, Andrew N; Hew, Mark; Peters, Matthew J; Gibson, Peter G; Christoff, George C; Popov, Todor A; Côté, Andréanne; Bergeron, Celine; Dorscheid, Delbert; FitzGerald, J Mark; Chapman, Kenneth R; Boulet, Louis Philippe; Bhutani, Mohit; Sadatsafavi, Mohsen; Jiménez-Maldonado, Libardo; Duran-Silva, Mauricio; Rodriguez, Bellanid; Celis-Preciado, Carlos Andres; Cano-Rosales, Diana Jimena; Solarte, Ivan; Fernandez-Sanchez, Maria Jose; Parada-Tovar, Patricia; von Bülow, Anna; Bjerrum, Anne Sofie; Ulrik, Charlotte S; Assing, Karin Dahl; Rasmussen, Linda Makowska; Hansen, Susanne; Altraja, Alan; Bourdin, Arnaud; Taille, Camille; Charriot, Jeremy; Roche, Nicolas; Papaioannou, Andriana I; Kostikas, Konstantinos; Papadopoulos, Nikolaos G; Salvi, Sundeep; Long, Deirdre; Mitchell, Patrick D; Costello, Richard; Sirena, Concetta; Cardini, Cristina.
Afiliación
  • Wechsler ME; Cohen Family Asthma Institute and Department of Medicine.
  • Scelo G; Observational and Pragmatic Research Institute, Singapore.
  • Larenas-Linnemann DES; Optimum Patient Care Global, Cambridge, United Kingdom.
  • Torres-Duque CA; Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, Mexico.
  • Maspero J; CINEUMO/Centro Internacional de Investigación en Neumología, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia.
  • Tran TN; Universidad de La Sabana, Chia, Colombia.
  • Murray RB; Clinical Research for Allergy and Respiratory Medicine, CIDEA Foundation, Buenos Aires, Argentina.
  • Martin N; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
  • Menzies-Gow AN; Optimum Patient Care Global, Cambridge, United Kingdom.
  • Hew M; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
  • Peters MJ; University of Leicester, Leicester, United Kingdom.
  • Gibson PG; AstraZeneca, Cambridge, United Kingdom.
  • Christoff GC; Royal Brompton & Harefield Hospitals, London, United Kingdom.
  • Popov TA; Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, Victoria, Australia.
  • Côté A; Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Bergeron C; Department of Thoracic Medicine, Concord Hospital, Sydney, New South Wales, Australia.
  • Dorscheid D; Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, New South Wales, Australia.
  • FitzGerald JM; Hunter Medical Research Institute, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • Chapman KR; Medical University, Sofia, Bulgaria.
  • Boulet LP; University Hospital Sv. Ivan Rilski, Sofia, Bulgaria.
  • Bhutani M; Department of Medicine, Laval University, Quebec City, Quebec, Canada.
  • Sadatsafavi M; Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
  • Jiménez-Maldonado L; Center for Heart Lung Innovation.
  • Duran-Silva M; Department of Medicine, and.
  • Rodriguez B; University of Toronto, Toronto, Ontario, Canada.
  • Celis-Preciado CA; Québec Heart and Lung Institute, Université Laval, Quebec City, Quebec, Canada.
  • Cano-Rosales DJ; Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Solarte I; Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Fernandez-Sanchez MJ; Fundación Neumológica Colombiana, Atención integral y rehabilitación en asma or Comprehensive Care and Rehabilitation in Asthma (ASMAIRE) Programa, Bogotá, Colombia.
  • Parada-Tovar P; Fundación Neumológica Colombiana, Atención integral y rehabilitación en asma or Comprehensive Care and Rehabilitation in Asthma (ASMAIRE) Programa, Bogotá, Colombia.
  • von Bülow A; Instituto Neumológico del Oriente, Bucaramanga, Colombia.
  • Bjerrum AS; Pulmonary Unit, San Ignacio University Hospital, Bogota, Colombia.
  • Ulrik CS; Faculty of Medicine, Pontificia University Javeriana, Bogota, Colombia.
  • Assing KD; Instituto Neumológico del Oriente, Bucaramanga, Colombia.
  • Rasmussen LM; Pulmonary Unit, San Ignacio University Hospital, Bogota, Colombia.
  • Hansen S; Faculty of Medicine, Pontificia University Javeriana, Bogota, Colombia.
  • Altraja A; Pulmonary Unit, San Ignacio University Hospital, Bogota, Colombia.
  • Bourdin A; Faculty of Medicine, Pontificia University Javeriana, Bogota, Colombia.
  • Taille C; CINEUMO/Centro Internacional de Investigación en Neumología, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia.
  • Charriot J; Respiratory Research Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark.
  • Roche N; Department of Respiratory Medicine and Allergy, Aarhus University Hospital, Aarhus City, Denmark.
  • Papaioannou AI; Department of Respiratory Medicine, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark.
  • Kostikas K; Department of Respiratory Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Papadopoulos NG; Allergy Clinic, Copenhagen University Hospital-Gentofte, Hellerup, Denmark.
  • Salvi S; Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, Denmark.
  • Long D; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Mitchell PD; Department of Pulmonology, University of Tartu and Lung Clinic, Tartu University Hospital, Tartu, Estonia.
  • Costello R; PhyMedExp, Université de Montpellier, Centre National de Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Sirena C; Department of Respiratory Diseases, Bichat Hospital, Public Assistance-Hospitals of Paris North, Paris City University, Paris, France.
  • Cardini C; PhyMedExp, Université de Montpellier, Centre National de Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Am J Respir Crit Care Med ; 209(3): 262-272, 2024 Feb 01.
Article en En | MEDLINE | ID: mdl-38016003
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Sinusitis / Productos Biológicos / Rinitis / Pólipos Nasales / Rinitis Alérgica Límite: Adult / Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Sinusitis / Productos Biológicos / Rinitis / Pólipos Nasales / Rinitis Alérgica Límite: Adult / Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article